Clinical studies recruiting near Malvern

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
Phase N/A · Cabrini Health · Monash University · NCT05180942 Pan Tumor Rollover Study
Phase 2 · Cabrini Hospital Malvern · Bristol-Myers Squibb · NCT03899155 HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
Phase 1/Phase 2 · Cabrini Health Limited · Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · NCT06649708 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414 A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
Phase 1 · Cabrini Hospital Malvern · BeOne Medicines · NCT07414836 Retrospective Analyses of TrakStar Database
Phase N/A · Neuronetics · Neuronetics · NCT06917339 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site AU61009 · Astellas Pharma Global Development, Inc. · NCT02960022 Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
Phase 1 · Cabrini Health Limited · PharmAbcine · NCT05957081 DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Cabrini Hospital · DynamiCure Biotechnology · NCT05785754 A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate,
Phase 1 · Cabrini Hospital Malvern · BeOne Medicines · NCT06625593 A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors
Phase 1 · Cabrini Health Limited · Antengene Biologics Limited · NCT05718895 A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Phase 1/Phase 2 · Cabrini Health · Hummingbird Bioscience · NCT05910827 A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Phase 1/Phase 2 · D3 Bio Investigative Site 0101 · D3 Bio (Wuxi) Co., Ltd · NCT05410145 Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced
Phase 1/Phase 2 · Cabrini Health Limited · Domain Therapeutics Australia Pty Ltd · NCT06819735 Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Phase N/A · Neuronetics · Neuronetics · NCT06997549 Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control
NA · Cabrini Health Ltd · Phantom Neuro Inc. · NCT07325708 ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Phase 1 · Cabrini Hospital · Adcendo ApS · NCT06597721 Trial of INI-4001 in Patients With Advanced Solid Tumours
Phase 1 · Cabrini Hospital · Inimmune Corporation · NCT06302426 A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Phase 1 · Cabrini Health Limited · Nested Therapeutics, Inc · NCT06326411 A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat
Phase 2/Phase 3 · Cabrini Hospital - Malvern · Bristol-Myers Squibb · NCT07221357 ARC101 in Advanced Solid Tumors
Phase 1 · Cabrini Health Research · Third Arc Bio · NCT06672185 TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Phase 1 · Cabrini Health · Treeline Biosciences, Inc. · NCT07082803 Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Phase 1 · Cabrini Health · Myeloid Therapeutics · NCT05969041 MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
Phase 2 · Cabrini Hospital · AUM Biosciences Pte Ltd · NCT05462236 Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With A
Phase 1 · Cabrini Hospital Malvern · BeOne Medicines · NCT06233942 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1149 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT06126224 Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HE
Phase 2 · Cabrini Health · Boehringer Ingelheim · NCT07486817 A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI i
Phase 1/Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07226986 Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy o
Phase 3 · Research Site · AstraZeneca · NCT06380751 A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Phase 1 · Eye Surgery Associates Pty Ltd · Therini Bio Pty Ltd · NCT06701721

Look up another city

Look up another condition